XPEL Reports Record Revenue of $124.7 Million; Revenue Growth of 13.5% in Second Quarter 2025
SAN ANTONIO–(BUSINESS WIRE)–XPEL, Inc. (Nasdaq: XPEL) (the “Company”), a global provider of protective films and coatings, announced consolidated... Read more.
LandBridge Announces Long-Term Surface Use and Pore Space Reservation Agreement with Devon Energy
10-year agreement reserves 300,000 bpd of low-pressure pore space capacity on LandBridge surface acreage Agreement includes a 175,000 bpd minimum volume commitment... Read more.
Energy Transfer Announces Natural Gas Pipeline Project to Serve Growing Southwestern U.S. Markets
Project Provides Increased Access to Prolific Permian Basin Natural Gas DALLAS–(BUSINESS WIRE)–Energy Transfer LP (NYSE: ET) today announced it has reached... Read more.
Bi/Multispecific Drugs in Oncology Analytical Service | Track Emerging Trends, and Capitalize on Groundbreaking Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Unlocking Opportunity: Dominate the Bi/Multispecific Drug Market with Confidence” report has been added to ResearchAndMarkets.com’s... Read more.
Milwaukee Is Holding up Better Than Any Other Major U.S. Housing Market
Redfin reports the majority of America’s most resilient housing markets are located in the Rust Belt and are seeing an increase in home sales and prices SEATTLE–(BUSINESS... Read more.
Intellicheck CEO Bryan Lewis To Present at the Sidoti Micro-Cap Virtual Conference on August 20th
MELVILLE, N.Y.–(BUSINESS WIRE)–$IDN #InvestorRelations–Intellicheck, Inc. (Nasdaq: IDN), an industry-leading identity company delivering proprietary... Read more.
Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without Incisions
Former FDA Director David Feigal joins Keyron as Head of Regulatory Affairs Dr Joyce Peetermans (ex-Boston Scientific) joins as Acting CTO Christopher Rowland (ex-Boston... Read more.
CrowdStrike Launches New Services to Secure AI Systems and Operationalize AI in the SOC
AI Systems Security Assessment and AI for SecOps Readiness expand CrowdStrike’s industry-leading AI Security Services portfolio, helping organizations reduce risk... Read more.
Vir Biotechnology Successfully Initiates all Trials in ECLIPSE Registrational Program for Chronic Hepatitis Delta
ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart... Read more.
CrowdStrike Signal Delivers the Next Evolution of AI-Powered Threat Detection
Now GA, new self-learning detection engines surface threats undetectable for others – connecting subtle activity into prioritized leads to accelerate investigation,... Read more.